Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Don't Get Too Worked Up Over Johnson & Johnson's Earnings
Motley Fool
Thu, 03/22/12 - 12:11 pm
Tags:
earnings, JNJ
J&J Unit Closes Facebook Page Due To Comments
Pharmalot
Wed, 03/21/12 - 11:26 am
Tags:
JNJ, social media, Facebook
Glaxo Joins J&J in $200 Million Fund With Index Ventures
Bloomberg
Wed, 03/21/12 - 10:06 am
Tags:
GSK, JNJ, venture capital
Johnson & Johnson Joins the Shareholder Revolution
Forbes
Mon, 03/19/12 - 09:20 am
Tags:
JNJ, shareholders
9 Pharma Buys for a Healthy Portfolio
Investor Place
Sun, 03/18/12 - 11:26 am
Tags:
Novo Nordisk, Valeant Pharmaceuticals, GSK, Abbott Laboratories, Eli Lilly, JNJ, Pfizer, Merck, Sanofi
6 Pharmaceuticals Paying 3%
Seeking Alpha
Sat, 03/17/12 - 12:10 pm
Tags:
Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, JNJ, Merck, Pfizer
Johnson & Johnson Passes This Key Test
Motley Fool
Sat, 03/17/12 - 10:50 am
Tags:
JNJ
J&J CEO Weldon retirement pay seen at $143.5 mln
Reuters
Thu, 03/15/12 - 09:07 am
Tags:
JNJ, William Weldon, executive pay
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Tags:
Seattle Genetics, Celldex, Arqule, Daiichi Sankyo, JNJ, Medivation, Dendreon, Aveo Pharmaceutical, Ariad Pharmaceuticals, AstraZeneca, Array Biopharma, Oncothyreon
A Drug Class Back From the Dead?
Motley Fool
Wed, 03/14/12 - 09:42 am
Tags:
Pfizer, Regeneron, JNJ, Sanofi, AstraZeneca, FDA, NGF blockers
Don't Expect Too Much From New Pain Drugs, Analyst Says
Forbes
Tue, 03/13/12 - 11:07 am
Tags:
painkillers, NGF blockers, Amgen, Regeneron, JNJ
Vical's Allovectin: Why Hasn't The Trial Been Stopped?
Seeking Alpha
Mon, 03/12/12 - 08:44 pm
Tags:
Vical, Allovectin, metastatic melanoma, melanoma, Zytiga, JNJ
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk
Yahoo/AP
Mon, 03/12/12 - 05:47 pm
Tags:
FDA, painkillers, Pfizer, JNJ, Regeneron, arthritis
J&J Said to Face Demand to Raise Risperdal Accord Offer by $800 Million
Bloomberg
Mon, 03/12/12 - 05:45 pm
Tags:
JNJ, Risperdal
Johnson & Johnson: A Solid Buy Candidate For 2012
Seeking Alpha
Mon, 03/12/12 - 05:30 pm
Tags:
JNJ
Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
Seeking Alpha
Sun, 03/11/12 - 12:12 pm
Tags:
Zytiga, Provenge, prostate cancer, JNJ, Dendreon
U.S. nixes tentative $1 bln settlement with J&J -WSJ
Reuters
Sat, 03/10/12 - 04:08 pm
Tags:
JNJ, legal, Risperdal
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
Tags:
JNJ, prostate cancer, Dendreon, Provenge, Medivation, Zytiga, MDV3100
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thu, 03/8/12 - 09:55 am
Tags:
Pfizer, JNJ, FDA, joint failure, painkillers, fulranumab, Sanofi, Regeneron, tanezumab, REGN475/SAR164877
US warns Synthes on violations; threatens fine
Reuters
Tue, 03/6/12 - 11:23 am
Tags:
Synthes, JNJ, warnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.